|Day Low/High||46.35 / 49.45|
|52 Wk Low/High||11.80 / 62.75|
After recent weakness in the biotech sector, here are some names to start watching.
Go on the offensive rather than turn defensive and miss the opportunities that are developing.
I'm keeping FIVE on the radar but will look for entry after it consolidates a bit.
There are several key points to keep in mind as you digest this news.
If the market wanted an excuse to sell off it had it.
The action started a little slowly this morning but market players shook off early jitters and are doing a nice job of building on yesterday's momentum.
In recent trading, shares of Zogenix Inc. have crossed above the average analyst 12-month target price of $52.67, changing hands for $55.90/share.
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Zogenix Inc. , where a total volume of 6,045 contracts has been traded thus far today, a contract volume which is representative of approximately 604,500 underlying shares (given that every 1 contract represents 100 underlying shares).
The good news is that there is some stock picking that is working well.
Will we see a trading range develop or will there be a continued effort to trend back to the recent highs?
Designation Based on Positive Results from Study 1, the First Pivotal Phase 3 Trial of ZX008
Investors in Zogenix Inc. saw new options become available this week, for the March 16th expiration.
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Zogenix Inc. , where a total of 5,943 contracts have traded so far, representing approximately 594,300 underlying shares.
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Zogenix Inc. , where a total of 4,378 contracts have traded so far, representing approximately 437,800 underlying shares.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.